CASI

CASI Pharmaceuticals, Inc. Ordinary Shares
Data: 2026-01-30
$1.02
Price
-0.01%
Change
$3.09
52W High
$0.75
52W Low

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Quick Stats
Jan 30, 2026

60.3

AI Score

BUY

1.29

Volume Ratio

Nov 21, 2025

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

CASI Stock Summary

Last updated Jan 30, 2026

CASI is currently trading at $1.02, positioned below its 200-day moving average of $1.55, suggesting bearish momentum. The stock has a 52-week range of $0.75 to $3.09.

Technical Analysis: The 50-day moving average stands at $0.96, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 54.327, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.146, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates CASI at 60.3/100 with a BUY recommendation.

CASI (CASI Pharmaceuticals, Inc. Ordinary Shares) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 54.327
CMF (20) 0.146
ROC (10) -1.923
ADX (14) 24.614
Indicator Value
MACD (12,26,9) 0.013
AROONOSC (14) -64.286
WILLAMS %R (14) -55.97
MFI (14) 57.577
CASI Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

CASI Price vs Max Options Open Interest
CASI Max Change In Options Open Interest

CASI Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CASI Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CASI Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

CASI Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

CASI Pharmaceuticals, Inc. Ordinary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

CASI Moving Averages Analysis

CASI Pharmaceuticals, Inc. Ordinary Shares has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

CASI (CASI Pharmaceuticals, Inc. Ordinary Shares) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 0.99
20 0.98
30 0.92
50 0.96
100 1.32
200 1.55

CASI Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 15.5 million
Earnings/Share ($) -3.02
Net Proft Margin (%) -1.8396
Dividend/Share ($) --
EPS Estimate Current Year ($) -2.58
EPS Estimate Next Year ($) -1.41
WallStreet Target Price ($) 4
Most Recent Quarter